1. Home
  2. BDSX vs ATOM Comparison

BDSX vs ATOM Comparison

Compare BDSX & ATOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$28.52

Market Cap

276.2M

Sector

Health Care

ML Signal

HOLD

Logo Atomera Incorporated

ATOM

Atomera Incorporated

HOLD

Current Price

$4.41

Market Cap

157.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
ATOM
Founded
2005
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
276.2M
157.7M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
BDSX
ATOM
Price
$28.52
$4.41
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.50
N/A
AVG Volume (30 Days)
90.0K
409.4K
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
4.41
EPS
N/A
N/A
Revenue
$88,499,000.00
$62,000.00
Revenue This Year
$25.26
$527.69
Revenue Next Year
$19.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.08
N/A
52 Week Low
$5.26
$1.89
52 Week High
$31.31
$12.37

Technical Indicators

Market Signals
Indicator
BDSX
ATOM
Relative Strength Index (RSI) 57.31 49.29
Support Level $19.26 $4.19
Resistance Level $31.31 $5.06
Average True Range (ATR) 1.67 0.19
MACD 0.02 0.08
Stochastic Oscillator 68.92 88.90

Price Performance

Historical Comparison
BDSX
ATOM

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

About ATOM Atomera Incorporated

Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used in the semiconductor industry. The company's silicon technology can be used for applications like Analog, DRAM, logic, processors, and SRAM. Geographically, it generates maximum revenue from North America.

Share on Social Networks: